Saturday, March 13, 2027 - 7:00 AM
to Sunday, March 14, 2027 - 12:00 PM
7:00 AM - 12:00 PM See all dates and Times
New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.
Educational Objectives
Upon completion of this activity, participants should be able to:
• Cite new strategies for identifying and managing metabolic liver disease.
• Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
• Discuss potential new treatments for alcohol-related liver disease.
• Summarize novel markers and therapies in PBC and PSC.
• Evaluate liver masses and new therapeutic options for HCC.
• Employ strategies for treating and managing ascites and hepatorenal syndrome.
Event Links
Tickets: https://go.evvnt.com/3870387-0
